Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2012
12/25/2012US8337853 Monoclonal antibodies that bind or neutralize dengue virus
12/25/2012US8337852 Anti-C5aR antibodies with improved properties
12/25/2012US8337850 4-1BB binding molecules
12/25/2012US8337849 Anti-IL6/IL-6R antibodies
12/25/2012US8337848 Monoclonal antibody for APP
12/25/2012US8337846 Immunogenic polypeptides and monoclonal antibodies
12/25/2012US8337845 A-beta binding polypeptides
12/25/2012US8337844 CD20-binding polypeptide compositions for treating autoimmune disease
12/25/2012US8337842 Monoclonal antibodies
12/25/2012US8337841 Methods of screening for antibody light chains
12/25/2012US8337840 Anti-CD19 antibodies
12/20/2012WO2012174446A1 Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer
12/20/2012WO2012174394A1 Methods of enhancing the response to radiation in tumor therapy using anti-dll4 antibodies
12/20/2012WO2012174178A1 Anti-angptl3 antibodies and uses thereof
12/20/2012WO2012174160A1 Tem8 antibodies, conjugates thereof, and their use
12/20/2012WO2012174001A1 Anti-psgl-1 antibodies and uses thereof
12/20/2012WO2012173244A1 Marker for use in detection of periodontopathic bacterium communicable between men and animals
12/20/2012WO2012172521A1 Soluble proteins for use as therapeutics
12/20/2012WO2012172495A1 Compositions and methods for antibodies targeting tem8
12/20/2012WO2012172102A1 Selective elimination of erosive cells
12/20/2012WO2012172070A1 Tumour necrosis factor receptor 1 antagonists
12/20/2012WO2012172034A1 Pharmaceutical composition comprising antibodies against catalase and superoxide dismutase for tumor therapy
12/20/2012WO2012171996A1 Anti-human epo receptor antibodies and methods of use
12/20/2012WO2012171896A1 Antibody binding to abca1 polypeptide
12/20/2012WO2012171104A1 Rabies virus like particle production in plants
12/20/2012WO2012171077A1 Method and composition for treatment or inhibition of mucositis associated with chemotherapy or radiation damage
12/20/2012WO2012171057A1 Antibodies against g-csfr and uses thereof
12/20/2012WO2012088461A3 Linker peptides and polypeptides comprising same
12/20/2012WO2012075333A3 Her2delta16 peptides
12/20/2012WO2012046061A3 Clostridium difficile antigens
12/20/2012WO2012024659A9 Antibody-based constructs directed against tyrosine kinase receptors
12/20/2012US20120322988 Therapeutic agent for use in a method of treating psoriasis or atopic dermatitis
12/20/2012US20120322987 Composition for repression of hyperlipidemia and obesity through suppression of intestinal cholesterol absorption
12/20/2012US20120322986 Compositions and methods for modulating lymphocyte activity
12/20/2012US20120322985 Foxo6 polyclonal antibody and method for preparing the same
12/20/2012US20120322984 Methods of reducing trail-induced apoptosis by trail isoforms
12/20/2012US20120322983 Method for purifying protein
12/20/2012US20120322982 Anti-vegf antibodies
12/20/2012US20120322981 Citrullination-specific phage display
12/20/2012US20120322975 Nucleic acids encoding antibodies that bind factor d
12/20/2012US20120322684 G-csf protein having a deletion of an amino acid sequence corresponding to exon 3 for use as a diagnostic cancer marker
12/20/2012US20120322672 Method for generating and selecting antibodies against target protein
12/20/2012US20120322156 Membrane fusion proteins derived from reovirus
12/20/2012US20120322149 Estrogen receptors and methods of use
12/20/2012US20120322105 Growth factor
12/20/2012US20120322089 Sensitive and generic antibodies and multiple applications
12/20/2012US20120322087 Method for examining acute renal disorder
12/20/2012US20120322085 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent
12/20/2012US20120322083 Antibody binding to abca1 polypeptide
12/20/2012US20120322082 Biomarker for amyotrophic lateral sclerosis and diagnostic kit and method used thereof
12/20/2012US20120322079 Method for testing or screening protein synthesis inhibitors
12/20/2012US20120322075 Lung Tumor Markers and Methods of Use Thereof
12/20/2012US20120322074 Prostate Tumor Markers and Methods of Use Thereof
12/20/2012US20120322073 Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
12/20/2012US20120322060 Diagnosis and monitoring treatment of psychiatric diseases with spadin and related methods
12/20/2012US20120321705 Lineage Restricted Glial Precursors from the Central Nervous System
12/20/2012US20120321699 Method of inducing the production of protective anti-hiv-1 antibodies
12/20/2012US20120321661 Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Malarial Infections
12/20/2012US20120321654 Infectious clones of torque teno virus
12/20/2012US20120321653 Novel chimeric polynucleotides and polypeptides enabling the secretion of a polypeptide of interest in combination with exosomes and uses thereof
12/20/2012US20120321651 Anti-IGE Vaccines
12/20/2012US20120321643 Anti-epidermal growth factor receptor antibodies and uses thereof
12/20/2012US20120321641 Pharmaceutical composition for treating and/or preventing cancer
12/20/2012US20120321640 Von willebrand factor specific binding agents and uses thereof
12/20/2012US20120321636 Antibodies specific for sclerostin and methods for increasing bone mineralization
12/20/2012US20120321635 Composition Containing Inhibitors of the Expression or Activity of SH3RF2 for Preventing or Treating Cancer
12/20/2012US20120321634 Estrogen receptors and methods of use
12/20/2012US20120321633 Anti-human epo receptor antibodies and methods of use
12/20/2012US20120321631 Anti-inflammatory agents
12/20/2012US20120321630 Antibodies against g-csfr and uses thereof
12/20/2012US20120321629 Stem cell factor inhibitor
12/20/2012US20120321628 Hepatocyte growth factor receptor antagonists and uses thereof
12/20/2012US20120321626 Multi-specific fab fusion proteins and methods of use
12/20/2012US20120321620 Methods and compositions for inhibiting cd32b expressing cells
12/20/2012US20120321619 Anti-c4.4a antibodies and uses thereof
12/20/2012US20120321618 Humanized anti-il 10 antibodies for the treatment of systemic lupus erythematosus (sle)
12/20/2012US20120321617 Humanized anti-il 10 antibodies for the treatment of systemic lupus erythematosus (sle)
12/20/2012US20120321616 Stabilized liquid anti-rsv antibody formulations
12/20/2012US20120321614 Antibodies to c-met
12/20/2012US20120321613 Molecular targets for healing or treating wounds
12/20/2012US20120321557 Anti-icam3 antibody and use thereof
12/20/2012US20120321554 Plexin d1 as a target for tumor diagnosis and therapy
12/20/2012CA2839755A1 Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer
12/20/2012CA2839009A1 Rabies virus like particle production in plants
12/20/2012CA2838973A1 Methods of enhancing the response to radiation in tumor therapy using anti-dll4 antibodies
12/20/2012CA2838952A1 Anti-psgl-1 antibodies and uses thereof
12/20/2012CA2838867A1 Anti-angptl3 antibodies and uses thereof
12/20/2012CA2838478A1 Soluble proteins for use as therapeutics
12/20/2012CA2838246A1 Antibodies against g-csfr and uses thereof
12/20/2012CA2838220A1 Selective elimination of erosive cells
12/20/2012CA2837914A1 Anti-human epo receptor antibodies and methods of use
12/20/2012CA2837892A1 Tem8 antibodies, conjugates thereof, and their use
12/20/2012CA2837030A1 Antibody binding to abca1 polypeptide
12/19/2012EP2535718A2 Methods for early diagnosis of kidney disease
12/19/2012EP2535358A1 Radioactive metal-labeled anti-cadherin antibody
12/19/2012EP2535357A1 Novel antibodies inhibiting C-MET dimerization, and uses thereof
12/19/2012EP2535356A1 Novel antibodies inhibiting C-MET dimerization, and uses thereof
12/19/2012EP2535355A2 Antibodies against CD38 for treatment of multiple myeloma
12/19/2012EP2535354A1 Antibodies to human programmed death receptor PD-1
12/19/2012EP2535353A1 Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 1494